SCHEMBL724009

SCHEMBL724009

CNC(=O)c1ccc(-c2ccnc3cc(-c4cc(OC)c(OC)c(OC)c4)oc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4C Q08493 1/20 0.41
FYN P06241 4/20 0.41
JAK2 O60674 3/20 0.40
JAK1 P23458 3/20 0.40
TYK2 P29597 2/20 0.40
JAK3 P52333 2/20 0.40
BRAF P15056 1/20 0.39
KDR P35968 1/20 0.39
ALDH1A1 P00352 3/20 0.39
CYP3A4 P08684 3/20 0.39
BRD4 O60885 1/20 0.39
HPGD P15428 2/20 0.39
CYP2C19 P33261 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
TUBB4A P04350 2/20 0.38
TUBB P07437 2/20 0.38
TUBA3C P0DPH7 2/20 0.38
TUBA1B P68363 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL721518 0.90 PDE4C (0.43) PDE4CFYNJAK2JAK1TYK2
SCHEMBL724106 0.89 PDE4C (0.44) PDE4CFYNJAK2JAK1TYK2
SCHEMBL722753 0.89 NEK2 (0.47) PDE4CFYNJAK2JAK1TYK2
SCHEMBL722431 0.88 MEN1 (0.48) ALDH1A1CYP3A4HPGDCYP2C19KDM4E
SCHEMBL10267307 0.88 CFTR (0.46) PDE4CFYNBRAFBRD4HPGD
SCHEMBL724898 0.86 FYN (0.52) FYNBRD4HPGD
SCHEMBL723997 0.85 MAPT (0.50) FYNALDH1A1CYP3A4HPGDCYP2C19
SCHEMBL723093 0.83 PDE4C (0.55) PDE4CFYNJAK2JAK1TYK2
SCHEMBL16638610 0.82 PDE4C (0.47) PDE4CJAK2JAK1TYK2JAK3
SCHEMBL722941 0.82 CYP1A1 (0.40) PDE4CFYNALDH1A1CYP3A4BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US claimed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
CN-103052640-A Furopyridine derivatives MERCK PATENT GMBH 2013-04-17 CN claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB PDE4C 2858/4885FYN 33/4885JAK2 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.